SG/CALL/EDWARDS LIFESCIENCES/65/0.1/17.01.25 | Delayed Deutsche Boerse AG 01:18:55 04/07/2024 am IST | ||
| 2.65 EUR | -3.28% |
|
| Current month | -7.34% | ||
| 1 month | +3.92% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 03/24/03 | 2.65 | -3.28% |
| 02/24/02 | 2.74 | +1.86% |
| 01/24/01 | 2.69 | -5.94% |
| 28/24/28 | 2.86 | -3.70% |
| 27/24/27 | 2.97 | +6.45% |
Delayed Quote Deutsche Boerse AG
Last update July 04, 2024 at 01:18 am IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU5D8A |
| ISIN | DE000SU5D8A9 |
| Date issued | 07/12/2023 |
| Strike | 65 $ |
| Maturity | 17/01/2025 (198 Days) |
| Parity | 10 : 1 |
| Emission price | 1.72 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.5 € |
|---|---|
| Lowest since issue | 1.63 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
91.08
USD
Average target price
96.13
USD
Spread / Average Target
+5.54%
- Stock Market
- Warrants
- Warrant
